95301 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
#1202IMIDE DERIVATIVE AND FUNGICIDE CONTAINING SAID DERIVATIVE AS ACTIVE INGREDIENT
#1203Protein degraders and uses thereof
#1204Sulfonyl acetamides as NLRP3 inhibitors
#1205Aminothiazole compounds as inhibitors of CTPS1
#1206Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
#1207NOVEL FORMULATION OF MELOXICAM
#1208Aryl cyclopropyl-amino-isoquinolinyl amide compounds
#1209PKM2 MODULATORS AND METHODS FOR THEIR USE
#1210Tead inhibitors and uses thereof
#1211Heterocyclic compounds for the treatment of neurological and psychological disorders
#1212SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#12133-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
#12144-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS
#1215Sulfonamide compound or salt thereof
#1216Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes
#1217Methods and compositions for selectively inhibiting pathogenic microbes
#1218SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
#1219Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
#1220Compounds and methods for the enhanced degradation of targeted proteins
#1221ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS AND METHODS
#1222NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
#12234-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
#1224Acid addition salts of piperazine derivatives
#1225Imidazole-based anticancer agents and derivatives thereof, and methods of making and using same
#1226NEW BENZIMIDAZOLES DERIVATIVES AS TEC KINASES FAMILY INHIBITORS
#1227Quinoline sulfonamide compounds and their use as antibacterial agents
#1228Insecticidal compounds based on isoxazoline derivatives
#1229Bicyclic-fused heteroaryl or aryl compounds
#1230DEGRADERS OF EGFR AND METHODS OF USE THEREOF
#1231Polymorphic forms of Dasatinib
#1232COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY AND DEGENERATIVE DISORDER
#1233Inhibitors
#1234Substituted piperazines as selective HDAC1,2 inhibitors
#1235Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6
#1236Inhibitors of metallo-beta-lactamases
#1237Compounds
#1238Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteric binders
#1239Pyridinamine-pyridone and pyrimidinamine- pyridone compounds
#1240Benzenesulfonamide compounds and their use as therapeutic agents
#1241COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES
#1242Isoxazole derivatives as FXR agonists and methods of use thereof
#1243NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
#1244TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#1245Compounds, compositions, and methods of increasing CFTR activity
#1246Quinoxaline derivatives as adenosine receptor antagonists
#1247Benzenesulfonamide compounds and their use as therapeutic agents
#1248Sulfonamide carboxamide compounds
#1249DNA-PK inhibitors
#1250Compounds and their use for reducing uric acid levels
#1251Compounds and compositions for inhibition of FASN
#1252Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
#12534-methylsulfonyl-substituted piperidine urea compounds
#1254Compounds and their use as inhibitors of N-myristoyl transferase
#1255CXCR2 antagonist
#1256Compounds and their use for reducing uric acid levels
#1257NOVEL COMPOUND AS INHIBITOR AGAINST BINDING OF PF34 PROTEIN TO NEDD4-1 PROTEIN AND USE THEREOF
#1258Phenoxymethyl derivatives
#1259Methods of synthesizing aztreonam derivatives
#1260Amide substituted indole compounds useful as TLR inhibitors
#12613-AMINO-[1,2,4]-TRIAZOLE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH
#1262Derivatives of luciferin and methods for their synthesis
#1263MCL-1 inhibitors
#1264Cannabinoid receptor mediating compounds
#1265C-Met Modulators and Methods of Use
#1266Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#1267Compounds and methods useful in the treatment of a PRMT5-mediated disorder
#1268TARGETED NITROXIDE AGENTS
#1269Cyclic peroxides as prodrugs for selective delivery of agents
#1270Compounds, Compositions and Methods
#1271Method for producing optically active compound
#1272Inhibiting ubiquitin specific peptidase 30
#1273Inhibitors of kinase networks and uses thereof
#1274Biguanide derivatives and their rearrangement products for use in the treatment of cancer
#1275Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors
#1276Androgen receptor modulating compounds
#1277WNT signaling pathway inhibitors for treatments of disease
#1278Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
#1279Type II raf kinase inhibitors
#1280Chemical compounds
#1281PCSK9 inhibitors and methods of use thereof
#1282RAD51 inhibitors
#1283PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#1284Enantiomers of substituted thiazoles as antiviral compounds
#1285Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes viruses
#1286Riluzole prodrugs and their use
#1287ORGANIC OPTICAL MATERIAL
#1288Compounds for improving mRNA splicing
#1289USE OF SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI
#1290MEK inhibitors and methods of their use
#1291Microbiocidal Thiazole Derivatives
#1292METHODS FOR TREATING VASCULAR LEAK SYNDROME
#1293Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor
#1294Microbiocidal quinoline (thio)carboxamide derivatives
#1295Pyridinium salt and pest control agent
#1296ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
#1297Therapeutic compounds as inhibitors of the orexin-1 receptor
#1298BENZOTHIAZOLE AND PYRIDOTHIAZOLE COMPOUNDS AS SUMO ACTIVATORS
#1299Compounds, salts thereof and methods for treatment of diseases
#1300Pyrimidinyloxy benzene derivatives as herbicides
#1301Microbiocidal oxadiazole derivatives
#1302SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY
#1303Factor XIIa inhibitors
#1304(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
#1305Microbiocidal quinoline (thio)carboxamide derivatives
#1306POLYMERIZABLE COMPOUND AND A PRODUCTION METHOD FOR SAME, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICAILLY ANISOTROPIC BODY, POLARIZING PLATE, DISPLAY DEVICE, ANTIREFLECTION FILM, AND COMPOUND AND USE FOR SAME
#13076-membered heterocyclic derivatives and pharmaceutical composition comprising the same
#1308Oxazolidinones as taro inhibitors
#1309TRPV4 antagonists
#1310Compositions and methods for treating cancer
#1311Thiophene compounds, process for synthesis and use thereof
#1312Quinazolines as potassium ion channel inhibitors
#1313Microbiocidal picolinamide derivatives
#13145-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME
#1315Hetero-halo inhibitors of histone deacetylase
#1316Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
#1317Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#1318Pharmacophores, compounds and methods having application in the treatment of cancer through inhibition of CYP17A1 and CYP19A1
#1319ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#1320Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use
#1321Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy
#1322TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF
#1323Inhibitors of protein kinases
#13245-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME
#13252,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against
#1326Pyrrole and pyrazole compounds and methods of use thereof
#1327Bi-functional compounds and methods for targeted ubiquitination of androgen receptor
#1328EBNA1 inhibitors and methods using same
#13293-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulators
#1330PCSK9 inhibitors and methods of use thereof
#1331Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#1332Cyanopyrrolidines as dub inhibitors for the treatment of cancer
#1333Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#1334Viral replication inhibitors
#1335FLUORO-CONTAINING COMPOUNDS, USE AND PREPARATION THEREOF
#1336Phenylpyridine derivative and pharmaceutical composition comprising the same
#1337Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
#1338Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#1339PPAR agonists and methods of use thereof
#1340Heterocycle amines and uses thereof
#1341RAD51 inhibitors
#1342BICYCLIC HETEROAROMATIC AMIDE COMPOUNDS FOR USE IN THERAPY
#1343BENZOFURAN UREAS OR CARBAMATES AND HETEROAROMATIC ANALOGUES THEREOF FOR USE IN THERAPY
#1344SULFONAMIDE DERIVATIVES AS STAT3 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#13455-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
#1346Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof
#1347Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells
#1348Tripartite androgen receptor eliminators, methods and uses thereof
#1349METHODS FOR TREATING VASCULAR LEAK SYNDROME
#1350Cyanopyrrolidine derivatives with activity as inhibitors of USP30
#1351Crystalline form of a BACE inhibitor, compositions, and use
#1352Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof
#1353Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
#1354Delta-opioid receptor agonists
#1355Modulators of estrogen receptor proteolysis and associated methods of use
#1356Diarylhydantoin compounds and methods of use thereof
#1357Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#1358Heteroarylphenylaminoquinolines and analogues
#1359NEUROPROTECTIVE HYDRAZIDES
#1360Compounds, compositions, and methods for increasing CFTR activity
#1361Compound used as autophagy regulator, and preparation method therefor and uses thereof
#1362PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#1363PPAR agonists
#1364Method of preparing glucosylceramide synthase inhibitors
#1365Compositions and methods for inhibition of the JAK pathway
#1366Carbazole compounds and methods of use thereof
#1367SUBSTITUTED 3-HETEROARYLOXY-1H-PYRAZOLES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES
#1368Microbiocidal oxadiazole derivatives
#13696-aminoisoquinoline compounds
#13701-cyano-pyrrolidine compounds as USP30 inhibitors
#1371NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE
#1372Deuterium-enriched pioglitazone
#1373Compound and pharmaceutical composition containing the same
#1374Small Molecule Sensitization of BAX Activation for Induction of Cell Death
#1375Pyridazinone compound or its salt, and herbicide containing it
#1376Compounds
#1377INHIBITORS OF CYCLIN-DEPENDENT KINASES
#1378Microbiocidal oxadiazole derivatives
#1379Pharmaceutical compound
#1380SUBSTITUTED 5-(HET-)ARYLPYRAZOLAMIDES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES
#1381HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING
#1382Thiazolyl-containing compounds for treating proliferative diseases
#1383Quinazoline and indole compounds to treat medical disorders
#1384Five membered-aminoheterocycle and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure
#1385NADPH oxidase 4 inhibitors
#1386Inhibitors of Rho associated coiled-coil containing protein kinase
#1387Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#1388Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
#1389Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
#1390Prodrugs of riluzole and their method of use
#1391Sulfonamide compound or salt thereof
#1392S1P3 antagonists
#1393Aryl-or heteroaryl-substituted benzene compounds
#1394Quinoline derivatives
#1395ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE
#1396Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein
#1397Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells
#1398Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
#1399Substituted phenyloxazolidinones for antimicrobial therapy
#1400Mast-cell modulators and uses thereof
#1401Heteroaryl sulfonamides and CCR2/CCR9
#1402ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS
#1403Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
#1404COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS
#1405Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#1406CFTR regulators and methods of use thereof
#1407SMALL MOLECULE MODULATORS OF HUMAN STING
#1408METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#1409Dual mechanism inhibitors for the treatment of disease
#1410Compounds for pain treatment, compositions comprising same, and methods of using same
#14111,3-thiazol-2-yl substituted benzamides
#1412Hepatitis B core protein modulators
#1413Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
#1414Pyrazole derivatives for the treatment of cystic fibrosis
#1415ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS
#1416AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS
#1417RAD51 inhibitors
#1418Protein kinase inhibitors
#1419THIAZOLE COMPOUNDS USEFUL AS PRMT5 INHIBITORS
#1420N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
#1421Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
#1422Hepatitis B capsid assembly modulators
#1423Composition, film, lens, solid state imaging element, and compounds
#1424Modulators of indoleamine 2,3-dioxygenase
#1425Modulation of Bacterial Quorum Sensing With Synthetic Ligands
#1426THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
#1427NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA
#1428DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#1429FUSED-BICYCLIC ARYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
#1430EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
#1431Methods for treating Huntington's disease
#14324-methylsulfonyl-substituted piperidine urea compounds
#1433Small molecule DCN1 inhibitors and therapeutic methods using the same
#1434PKM2 modulators and methods for their use
#1435Sulfur derivatives as chemokine receptor modulators
#1436COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#1437Substituted isoindole allosteric EGFR inhibitors
#1438Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
#1439Aryl cyclopropyl-amino-isoquinolinyl amide compounds
#1440WDR5 inhibitors and modulators
#1441Tricyclic spiro compound
#1442Carboxylic acid derivative as ATR receptor antagonist
#1443Inhibitors of integrated stress response pathway
#1444Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
#1445N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
#1446Quinoline and isoquinoline derivatives for treating pain and pain related conditions
#1447Compounds and compositions for treating conditions associated with NLRP activity
#1448Selective ligand for dopamine D3 receptor, preparation method therefor, and pharmaceutical application thereof
#1449Small molecule regulators of steroid receptor coactivators and methods of use thereof
#14502,4-pyrimidinediamine compounds and their uses
#1451Riluzole prodrugs and their use
#1452Pesticidal Compounds
#1453Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
#1454Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#1455Sulfonamides as inhibitors of the uptake of extracellular citrate
#1456KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#1457Compounds and methods for the targeted degradation of androgen receptor
#1458Chemokine CXCR4 receptor modulators and uses related thereto
#1459Conjugated polymers based on terthiophene and their applications
#1460T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS
#1461MYC MODULATORS AND USES THEREOF
#1462Acyl sulfonamide NaV1.7 inhibitors
#1463Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound
#1464Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators
#1465SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS
#1466SUBSTITUTED BENZAMIDES
#1467Hybridoma cell line of secreting meloxicam monoclonal antibodies and application thereof
#1468Compounds and methods for inhibiting fascin
#1469Processes for the preparation of a BACE inhibitor
#1470SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS
#1471Compounds
#1472Cathepsin-D and angiogenesis inhibitors and compositions thereof for treating breast cancer
#1473Insecticidal compounds
#1474Insecticidal compounds
#1475MEK INHIBITORS AND METHODS OF THEIR USE
#1476Quinone-containing conjugates
#1477Compounds for treatment of cancer
#1478Compounds having estrogen receptor alpha degradation activity and uses thereof
#1479Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
#1480Chromobox protein inhibitors and uses thereof
#1481Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
#1482Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#1483Heterocyclic inhibitors of the sodium channel
#1484Compounds and their use for reducing uric acid levels
#1485Compounds and their use for reducing uric acid levels
#14864-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same
#1487Compounds and compositions for inhibition of FASN
#1488Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors
#1489Azole compounds as ubiquitin-specific protease USP7 inhibitors
#1490Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
#1491Piperazine derivatives for influenza virus inhibitions
#1492PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#1493Urea derivative or pharmacologically acceptable salt thereof
#1494DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#1495Phenyl and pyridinyl hydroxamic acids
#1496Display inserts, overlays, and graphical user interfaces for multimedia systems
#1497Pyridyl derivatives as bromodomain inhibitors
#1498FUNGICIDAL PYRAZOLES
#1499Sulfoximine glycosidase inhibitors
#1500Process for making Hepatitis B core protein modulators